ethylenediamine has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boullier, A; Lohou, E; Sasaki, NA; Sonnet, P | 1 |
1 other study(ies) available for ethylenediamine and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Multifunctional diamine AGE/ALE inhibitors with potential therapeutical properties against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Copper; Diamines; Glycation End Products, Advanced; Lipid Peroxidation; Malondialdehyde; PC12 Cells; Pyruvaldehyde; Rats; Reactive Oxygen Species | 2016 |